The European Commission has approved, under the EU Merger Regulation, the creation of a joint venture, E-VITA GmbH, by Ceravis AG and Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung (Frauenhofer-Gesellschaft), throughout all of Germany.
The joint venture will market, use, distribute, and develop electron technology for chemical-free seed treatment.
Ceravis belongs to the Danish Agro Group of Denmark and is active in agricultural trade as well as production of seeds and animal feed, primarily for farmers in northern Germany. Fraunhofer-Gesellschaft conducts application-oriented research as well as contract research for government agencies and the private sector.
The Commission concluded that the proposed creation of a joint venture would raise no competition concerns, given the limited foreseen activities of E-VITA in the European Economic Area. The transaction was examined under the simplified merger review procedure.
Featured News
Judge Appoints Law Firms to Lead Consumer Antitrust Litigation Against Apple
Dec 22, 2024 by
CPI
Epic Health Systems Seeks Dismissal of Antitrust Suit Filed by Particle Health
Dec 22, 2024 by
CPI
Qualcomm Secures Partial Victory in Licensing Dispute with Arm, Jury Splits on Key Issues
Dec 22, 2024 by
CPI
Google Proposes Revised Revenue-Sharing Limits Amid Antitrust Battle
Dec 22, 2024 by
CPI
Japan’s Antitrust Authority Expected to Sanction Google Over Monopoly Practices
Dec 22, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – CRESSE Insights
Dec 19, 2024 by
CPI
Effective Interoperability in Mobile Ecosystems: EU Competition Law Versus Regulation
Dec 19, 2024 by
Giuseppe Colangelo
The Use of Empirical Evidence in Antitrust: Trends, Challenges, and a Path Forward
Dec 19, 2024 by
Eliana Garces
Some Empirical Evidence on the Role of Presumptions and Evidentiary Standards on Antitrust (Under)Enforcement: Is the EC’s New Communication on Art.102 in the Right Direction?
Dec 19, 2024 by
Yannis Katsoulacos
The EC’s Draft Guidelines on the Application of Article 102 TFEU: An Economic Perspective
Dec 19, 2024 by
Benoit Durand